This is a non-material governance event with no immediate trading implications. Monitor for any future updates on financing strategy given the new director's debt-financing background, but no actionable catalyst at this time.
Price Chart
Executive Summary
XORTX Therapeutics announced the appointment of Depesh Narotam as an independent director effective July 27, 2026. Mr. Narotam brings over 20 years of financial services and debt financing expertise, but no material financial commitments or strategic changes are disclosed. This is a routine board appointment with no immediate stock price catalysts.
Key Facts
- Depesh Narotam appointed as independent director effective July 27, 2026
- Narotam to serve on Compensation, Governance and Nominating Committee
- No financial terms, clinical data, or guidance provided in the filing
Financial Impact
No financial impact; routine director appointment with no disclosed compensation or deal terms.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004972 |
| Document: f6k_072926.htm | 0001171843-26-004972 |
| Document: 0001171843-26-004972-index-headers.html | 0001171843-26-004972 |
| Document: 0001171843-26-004972-index.html | 0001171843-26-004972 |
| Document: 0001171843-26-004972.txt | 0001171843-26-004972 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 17d ago | 6-K | $1.41 | awaiting T+20 | — | $0.8500 (−39.72%) |
Sep 18, 2026 5w ago | 6-K | $1.92 $1.24 | ▼ −35.42% | ▼ −35.62% | $0.8500 (−55.73%) |
Sep 18, 2026 5w ago | Press Release | $1.92 $1.24 | ▼ −35.42% | ▼ −35.62% | $0.8500 (−55.73%) |
Sep 4, 2026 7w ago | 6-K | $2.31 $1.70 | ▲ +26.41% | ▲ +27.01% | $0.8500 (+63.20%) |
Aug 28, 2026 8w ago | 6-K | $2.34 $1.71 | ▼ −26.86% | ▼ −27.12% | $0.8500 (−63.64%) |
Aug 3, 2026 11w ago | 6-K | $2.16 $2.16 | · 0.00% | ▲ +1.24% | $0.8500 (−60.65%) |
Jul 29, 2026 12w ago | 6-K | $2.06 $2.22 | ▲ +7.67% | ▲ +2.65% | $0.8500 (−58.74%) |
Jun 15, 2026 19w ago | 6-K | $2.19 $2.03 | ▼ −7.31% | ▼ −6.56% | $0.8500 (−61.19%) |
Jun 12, 2026 19w ago | 6-K | $2.19 $2.03 | ▼ −7.31% | ▼ −6.56% | $0.8500 (−61.19%) |
May 19, 2026 22w ago | 6-K / PRESS-RELEASE | $2.32 $2.15 | ▲ +7.33% | ▲ +8.31% | $0.8500 (+63.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers